Home
Search results “Pharmacotherapy practice and principles”
Principles of Pharmacotherapy
 
00:59
Principles and considerations of prescribing medication for practitioners.
Views: 185 Wanda France
Pharmacotherapy
 
00:56
Views: 10 Enyi Lee
Pharmacotherapy Principles and Practice
 
00:33
http://erj-books.club/readonline/?item=0071801782&lan=en
Views: 6 Jessie Ballard
1. Pharmacotherapy Principles and Practice 4th Edition (2016)
 
23:47
Pharmacotherapy Principles and Practice 4th Edition (2016) ---------(Video 1) --PART I: BASIC CONCEPTS OF PHARMACOTHERAPY PRINCIPLES AND PRACTICES 1 --PART II: DISORDERS OF ORGAN SYSTEMS 43 SECTION 1. Cardiovascular Disorders 45 SECTION 2. Respiratory Disorders 241 SECTION 3. Gastrointestinal Disorders 285 SECTION 4.Renal Disorders 387 SECTION 5. Neurologic Disorders 451 ---------(Video 2) SECTION 6. Psychiatric Disorders 545 SECTION 7. Endocrinologic Disorders 651 SECTION 8. Gynecologic and Obstetric Disorders 729 SECTION 9. Urologic Disorders 787 SECTION 10. Immunologic Disorders 829 SECTION 11. Bone and Joint Disorders 863 SECTION 12. Disorders of the Eyes, Ears, Nose, and Throat 921 SECTION 13. Dermatologic Disorders 965 SECTION 14. Hematologic Disorders 993 ---------(Video 3) SECTION 15. Diseases of Infectious Origin 1033 SECTION 16. Oncologic Disorders 1289 SECTION 17. Nutrition and Nutritional Disorders 1489
3. Pharmacotherapy Principles and Practice 4th Edition (2016)
 
25:12
Pharmacotherapy Principles and Practice 4th Edition (2016) ---------(Video 1) --PART I: BASIC CONCEPTS OF PHARMACOTHERAPY PRINCIPLES AND PRACTICES 1 --PART II: DISORDERS OF ORGAN SYSTEMS 43 SECTION 1. Cardiovascular Disorders 45 SECTION 2. Respiratory Disorders 241 SECTION 3. Gastrointestinal Disorders 285 SECTION 4.Renal Disorders 387 SECTION 5. Neurologic Disorders 451 ---------(Video 2) SECTION 6. Psychiatric Disorders 545 SECTION 7. Endocrinologic Disorders 651 SECTION 8. Gynecologic and Obstetric Disorders 729 SECTION 9. Urologic Disorders 787 SECTION 10. Immunologic Disorders 829 SECTION 11. Bone and Joint Disorders 863 SECTION 12. Disorders of the Eyes, Ears, Nose, and Throat 921 SECTION 13. Dermatologic Disorders 965 SECTION 14. Hematologic Disorders 993 ---------(Video 3) SECTION 15. Diseases of Infectious Origin 1033 SECTION 16. Oncologic Disorders 1289 SECTION 17. Nutrition and Nutritional Disorders 1489
Applying the Principles of DBT in the Practice of Pharmacotherapy. Suzanne Witterholt (2014) HD
 
52:04
Suzanne Witterholt, M.D., has worked for the Minnesota Department of Human Services since 1994. For over six years, she directed a DBT inpatient unit at the Anoka Metro Regional Treatment Center. Subsequently, she turned her attention to the development of the community’s capacity to effectively treat people with Borderline Personality Disorder and related conditions. Since February, 2006, she has been working with treatment developer, Marsha Linehan, PhD; to implement DBT certification of clinicians and programs based on the evidenced based fidelity standards of the model. Currently, she is a on the Board of Directors of the DBT-Linehan Board of Certification. Having consulted extensively in Minnesota and throughout the United States, she is actively involved in the teaching and implementation of DBT in the public mental health sector. In recognition of her work, she has been named a Distinguished Fellow of the American Psychiatric Association. Source: The Linehan Institute Uploaded for educational purposes only.
Study Strategies | How I study for exams: Pharmacotherapeutics edition
 
12:30
↓ OPEN THIS FOR MORE INFO ↓ If you have any questions, feel free to leave a comment, email, or message me on social media! Find me on social media!!! INSTAGRAM: @alyssabissa89 SNAPCHAT: alyssabissa89 For general questions or business inquiries, email me at [email protected]
Views: 1232 Alyssa Marie
The app for Pharmacotherapy Principles And Practice, 4/E is now available for mobile devices
 
02:06
The app for Pharmacotherapy Principles And Practice, Fourth Edition is now available for mobile devices. See below for app store links. iOS app: https://itunes.apple.com/us/app/pharmacotherapy-principles-4-e/id1388049731?ls=1&mt=8 Android app: https://play.google.com/store/apps/details?id=com.usatineMediaLLC.pharmacotherapy4e Learn more: http://www.usatinemedia.com/
Views: 27 Usatine Media
1.3 Basic Pharmacology Principles 1
 
59:30
This video has been rerecorded into small videos, check out the Basic Principles in Pharmacology playlist.
Views: 414885 PHRM203
Motivational Interviewing: Clinical Practice with Pharmacotherapy
 
01:13:58
NAADAC's Life-Long Learning Series Motivational Interviewing: Clinical Practice with Pharmacotherapy educational program will discuss the four principles of Motivational Interviewing; motivating patients in treatment using the Stages of Change model; the four medications approved by the Food and Drug Administration (FDA) for treatment of alcohol dependence; matching patients to the most appropriate pharmacotherapy given their readiness to change; and specific interviewing methods and skills for alcohol dependent patients considering pharmacotherapy. The goal of this educational program is to introduce addiction and other helping professionals to the specific skills necessary for integrating Motivational Interviewing and pharmacotherapy with the Stages of Change model.
2. Pharmacotherapy Principles and Practice 4th Edition (2016)
 
20:22
Pharmacotherapy Principles and Practice 4th Edition (2016) ---------(Video 1) --PART I: BASIC CONCEPTS OF PHARMACOTHERAPY PRINCIPLES AND PRACTICES 1 --PART II: DISORDERS OF ORGAN SYSTEMS 43 SECTION 1. Cardiovascular Disorders 45 SECTION 2. Respiratory Disorders 241 SECTION 3. Gastrointestinal Disorders 285 SECTION 4.Renal Disorders 387 SECTION 5. Neurologic Disorders 451 ---------(Video 2) SECTION 6. Psychiatric Disorders 545 SECTION 7. Endocrinologic Disorders 651 SECTION 8. Gynecologic and Obstetric Disorders 729 SECTION 9. Urologic Disorders 787 SECTION 10. Immunologic Disorders 829 SECTION 11. Bone and Joint Disorders 863 SECTION 12. Disorders of the Eyes, Ears, Nose, and Throat 921 SECTION 13. Dermatologic Disorders 965 SECTION 14. Hematologic Disorders 993 ---------(Video 3) SECTION 15. Diseases of Infectious Origin 1033 SECTION 16. Oncologic Disorders 1289 SECTION 17. Nutrition and Nutritional Disorders 1489
Antibacterials - CRASH! Medical Review Series
 
34:23
(Disclaimer: The medical information contained herein is intended for physician medical licensing exam review purposes only, and are not intended for diagnosis of any illness. If you think you may be suffering from any medical condition, you should consult your physician or seek immediate medical attention.)
Views: 151569 Paul Bolin, M.D.
Pharmacotherapy of Burn Patient Management
 
26:06
PHAR3415 CUHK School of Pharmacy
Views: 690 Justin Tenney
Chemotherapeutic agents
 
16:29
This is a brief overview of chemotherapeutic agents, their mechanism of action, and some related side effects. I created this presentation with Google Slides. Image were created or taken from Wikimedia Commons I created this video with the YouTube Video Editor. ADDITIONAL TAGS: Chemotherapeutic agents Classes of chemical agents used in the treatment of cancer Alkylating agents Antimetabolites Microtubule targeting agents Topoisomerase inhibitors Anthracyclines Monoclonal antibodies Other agents Alkylating agents Attach alkyl groups to DNA, allows cross linking of base pairs, damaging DNA; cell cycle nonspecific Typical alkylating agents: cyclophosphamide, ifosfamide, melphalan, busulfan, mechlorethamine, chlorambucil, thiotepa Side effects: myelosuppression drop in WBC, Hb, crit, nausea/vomiting, secondary malignancies, infertility/impaired fertility, hemorrhagic cystitis hematuria, dysuria from direct irritation of bladder by acrolein metabolite Atypical alkylating agents Platinum compounds covalently bind purine DNA bases. Drugs and side effects: cisplatin causes nephrotoxicity and n/v carboplatin causes thrombocytopenia oxaliplatin causes cold sensitivity all cause peripheral neuropathies, paresthesia Nitrosoureas: BCNu, CCNu both cause pulmonary toxicity, phlebitis. CNS Alkylating agents Antimetabolites Microtubule targeting agents Topoisomerase inhibitors Anthracyclines Monoclonal antibodies Other agents Antimetabolites Inhibit DNA replication or repair by mimicking normal cell compounds; S phase specific Folate inhibitor: Methotrexate inhibits DHFR, prevents regeneration of THF Adjuvant leucovorin to protect healthy cells adjuvant Side effect is mucositis, myelosuppression Pyrimidine inhibitors 5-fluorouracil inhibits thymidylate synthetase Bolus dose causes myelosuppression Continuous dose causes GI problems mucositis, diarrhea Synergistic leucovorin potentate mechanism of action synergistic Capecitabine is essentially an oral prodrug for 5-FU Side effect: hand-foot syndrome - palms and hands and feet become red, can start blistering Cytarabine AraC is a DNA chain terminator Side effects: conjunctivitis and cerebellar neural defects The 7 in 7+3 chemotherapy Purine analog is 6-mercaptopurine Alkylating agents Antimetabolites Microtubule targeting agents Topoisomerase inhibitors Anthracyclines Monoclonal antibodies Other agents Microtubule targeting agents These drugs inhibit mitosis, specifically M phase Vinca alkaloids destroy microtubules, obviously preventing their function Vincristine, vinblastine, and vinorelbine Side effects: peripheral neuropathy, myelosuppressive blast others Fatal if given intrathecally Taxanes stabilize microtubules, preventing their function Paclitaxol, docetaxol Side effects: myelosuppression, peripheral neuropathies Hypersensitivity from diluent: Cremophor diluent in paclitaxel Tween80 in docetaxel Avoid hypersenitivity with abraxane, protein-bound paclitaxol particles less sensitivity but more neuropathy Topoisomerase inhibitors Topoisomerase I inhibitors prevent relaxation of supercoiled DNA Topotecan, irinotecan Both have side effect of myelosuppression Irinotecan causes diarrhea: “I ran to the can” Topoisomerase II inhibitors prevent recoiling of DNA after transcription Etoposide, teniposide Both have side effects of myelosuppression, mucositis, secondary malignancies AML Etoposide also causes hypotension Anthracyclines Various mechanisms of action: intercalate DNA, inhibit topo II, generate ROS, perhaps alkylation -rubicins: doxorubicin, daunorubicin, idarubicin, epirubicin Side effects: biventricular heart failure, necrotic with extravasation The 3 in 7+3 chemotherapy Monoclonal antibodies Origin determined from suffixes: -omab from mouse; -ximab is chimeric cross between human/mouse; -umab is humanized; -mumab is fully human mAb Target Treats: Toxicity Rituximab CD20 lymphoma - Trastuzumab Her-2 breast cancer - Cetuximab EGFR solid tumors initially for colorectal cancer Acneiform rash Bevacizumab VEGF solid tumors initially for colorectal/lung cancers GI perforation, Other chemotherapeutic agents Bleomycin causes lung toxicity Side effects: pulmonary fibrosis, interstitial pneumonitis, hypersensitivity pneumonitis cough, infiltrates Hormonal therapies Antiestrogens block estrogen stimulation of breast cancer Tamoxifen, fulvestrant, megestrol acetate Aromatase inhibitors block synthesis of estrogen Anastrozole, letrozole Antiandrogens block androgen stimulation of prostate cancer Other targets for prostate cancer are LHRH agonists prevent testosterone production, GnRH antagonist, CYP17 inhibitor
Views: 125278 MedLecturesMadeEasy
Dr. Russell Portenoy - Principles of Opioid Prescribing including Safe Practices
 
01:00:16
Dr. Russell K. Portenoy, Chairman, Dept of Pain Medicine and Palliative Care, Beth Israel Medical Center.
Views: 13849 painpallcare
HAART treatment for HIV - Who, what, why, when, and how | NCLEX-RN | Khan Academy
 
08:37
Visit us (http://www.khanacademy.org/science/healthcare-and-medicine) for health and medicine content or (http://www.khanacademy.org/test-prep/mcat) for MCAT related content. These videos do not provide medical advice and are for informational purposes only. The videos are not intended to be a substitute for professional medical advice, diagnosis or treatment. Always seek the advice of a qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read or seen in any Khan Academy video. Created by Vishal Punwani. Watch the next lesson: https://www.khanacademy.org/test-prep/nclex-rn/rn-infectious-diseases/rn-hiv-and-aids/v/defining-aids-and-aids-defining-illnesses-bumper?utm_source=YT&utm_medium=Desc&utm_campaign=Nclex-rn Missed the previous lesson? https://www.khanacademy.org/test-prep/nclex-rn/rn-infectious-diseases/rn-hiv-and-aids/v/treating-hiv-antiretroviral-drugs?utm_source=YT&utm_medium=Desc&utm_campaign=Nclex-rn NCLEX-RN on Khan Academy: A collection of questions from content covered on the NCLEX-RN. These questions are available under a Creative Commons Attribution-NonCommercial-ShareAlike 3.0 United States License (available at http://creativecommons.org/licenses/by-nc-sa/3.0/us/). About Khan Academy: Khan Academy offers practice exercises, instructional videos, and a personalized learning dashboard that empower learners to study at their own pace in and outside of the classroom. We tackle math, science, computer programming, history, art history, economics, and more. Our math missions guide learners from kindergarten to calculus using state-of-the-art, adaptive technology that identifies strengths and learning gaps. We've also partnered with institutions like NASA, The Museum of Modern Art, The California Academy of Sciences, and MIT to offer specialized content. For free. For everyone. Forever. #YouCanLearnAnything Subscribe to Khan Academy’s NCLEX-RN channel: https://www.youtube.com/channel/UCDx5cTeADCvKWgF9x_Qjz3g?sub_confirmation=1 Subscribe to Khan Academy: https://www.youtube.com/subscription_center?add_user=khanacademy
Views: 93692 khanacademymedicine
DIMENSIONS: Tobacco Pharmacotherapy
 
47:07
This one-hour presentation covers the following topics: - Biology of tobacco dependence - Symptoms and duration of nicotine withdrawal - Information on all approved tobacco cessation medications and combination therapies - Special considerations for at-risk populations A similar PDF of this presentation (developed for the Build a Clinic program) is available from the Behavioral Health & Wellness Program website here: https://www.bhwellness.org/wp-content/uploads/BAC-Module-02-FINAL.pdf